Biopharmaceutical Third-party Logistics - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510240616

Publication Date:

October 14, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Biopharmaceutical Third-party Logistics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Third-party Logistics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Third-party Logistics by region & country, by Type, and by Application.
The Biopharmaceutical Third-party Logistics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Third-party Logistics.
麻豆原创 Segmentation
By Company
DHL International GmbH
SF Express
United Parcel Service of America
AmerisourceBergen Corporation
DB Schenker
Kuehne and Nagel
Kerry Logistics Network
Agility Logistics
McKesson Corporation
Segment by Type:
Cold Chain
Non-cold Chain
Segment by Application
Transportation
Storage
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biopharmaceutical Third-party Logistics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biopharmaceutical Third-party Logistics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biopharmaceutical Third-party Logistics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Biopharmaceutical Third-party Logistics Product Introduction
1.2 Global Biopharmaceutical Third-party Logistics 麻豆原创 Size Forecast
1.3 Biopharmaceutical Third-party Logistics 麻豆原创 Trends & Drivers
1.3.1 Biopharmaceutical Third-party Logistics Industry Trends
1.3.2 Biopharmaceutical Third-party Logistics 麻豆原创 Drivers & Opportunity
1.3.3 Biopharmaceutical Third-party Logistics 麻豆原创 Challenges
1.3.4 Biopharmaceutical Third-party Logistics 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharmaceutical Third-party Logistics Players Revenue Ranking (2023)
2.2 Global Biopharmaceutical Third-party Logistics Revenue by Company (2019-2024)
2.3 Key Companies Biopharmaceutical Third-party Logistics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharmaceutical Third-party Logistics Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Third-party Logistics
2.6 Biopharmaceutical Third-party Logistics 麻豆原创 Competitive Analysis
2.6.1 Biopharmaceutical Third-party Logistics 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Third-party Logistics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Third-party Logistics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cold Chain
3.1.2 Non-cold Chain
3.2 Global Biopharmaceutical Third-party Logistics Sales Value by Type
3.2.1 Global Biopharmaceutical Third-party Logistics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharmaceutical Third-party Logistics Sales Value, by Type (2019-2030)
3.2.3 Global Biopharmaceutical Third-party Logistics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Transportation
4.1.2 Storage
4.1.3 Other
4.2 Global Biopharmaceutical Third-party Logistics Sales Value by Application
4.2.1 Global Biopharmaceutical Third-party Logistics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharmaceutical Third-party Logistics Sales Value, by Application (2019-2030)
4.2.3 Global Biopharmaceutical Third-party Logistics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharmaceutical Third-party Logistics Sales Value by Region
5.1.1 Global Biopharmaceutical Third-party Logistics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharmaceutical Third-party Logistics Sales Value by Region (2019-2024)
5.1.3 Global Biopharmaceutical Third-party Logistics Sales Value by Region (2025-2030)
5.1.4 Global Biopharmaceutical Third-party Logistics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.2.2 North America Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.3.2 Europe Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.5.2 South America Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharmaceutical Third-party Logistics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharmaceutical Third-party Logistics Sales Value
6.3 United States
6.3.1 United States Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.3.2 United States Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.4.2 Europe Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.5.2 China Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.6.2 Japan Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.7.2 South Korea Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.9.2 India Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 DHL International GmbH
7.1.1 DHL International GmbH Profile
7.1.2 DHL International GmbH Main Business
7.1.3 DHL International GmbH Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.1.4 DHL International GmbH Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.1.5 DHL International GmbH Recent Developments
7.2 SF Express
7.2.1 SF Express Profile
7.2.2 SF Express Main Business
7.2.3 SF Express Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.2.4 SF Express Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.2.5 SF Express Recent Developments
7.3 United Parcel Service of America
7.3.1 United Parcel Service of America Profile
7.3.2 United Parcel Service of America Main Business
7.3.3 United Parcel Service of America Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.3.4 United Parcel Service of America Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.3.5 AmerisourceBergen Corporation Recent Developments
7.4 AmerisourceBergen Corporation
7.4.1 AmerisourceBergen Corporation Profile
7.4.2 AmerisourceBergen Corporation Main Business
7.4.3 AmerisourceBergen Corporation Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.4.4 AmerisourceBergen Corporation Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.4.5 AmerisourceBergen Corporation Recent Developments
7.5 DB Schenker
7.5.1 DB Schenker Profile
7.5.2 DB Schenker Main Business
7.5.3 DB Schenker Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.5.4 DB Schenker Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.5.5 DB Schenker Recent Developments
7.6 Kuehne and Nagel
7.6.1 Kuehne and Nagel Profile
7.6.2 Kuehne and Nagel Main Business
7.6.3 Kuehne and Nagel Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.6.4 Kuehne and Nagel Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.6.5 Kuehne and Nagel Recent Developments
7.7 Kerry Logistics Network
7.7.1 Kerry Logistics Network Profile
7.7.2 Kerry Logistics Network Main Business
7.7.3 Kerry Logistics Network Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.7.4 Kerry Logistics Network Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.7.5 Kerry Logistics Network Recent Developments
7.8 Agility Logistics
7.8.1 Agility Logistics Profile
7.8.2 Agility Logistics Main Business
7.8.3 Agility Logistics Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.8.4 Agility Logistics Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.8.5 Agility Logistics Recent Developments
7.9 McKesson Corporation
7.9.1 McKesson Corporation Profile
7.9.2 McKesson Corporation Main Business
7.9.3 McKesson Corporation Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.9.4 McKesson Corporation Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.9.5 McKesson Corporation Recent Developments
8 Industry Chain Analysis
8.1 Biopharmaceutical Third-party Logistics Industrial Chain
8.2 Biopharmaceutical Third-party Logistics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharmaceutical Third-party Logistics Sales Model
8.5.2 Sales Channel
8.5.3 Biopharmaceutical Third-party Logistics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

DHL International GmbH
SF Express
United Parcel Service of America
AmerisourceBergen Corporation
DB Schenker
Kuehne and Nagel
Kerry Logistics Network
Agility Logistics
McKesson Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.